You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Noninvasive Platform to Assess Maternal Risk for Perinatal Complications in the First Trimester
SBC: Cradle Genomics, Inc. Topic: NICHDLimited information is available about early human placentation when many pregnancy pathologies originateTo address this knowledge gap and begin development of robust diagnostic tool to manage pregnancy complicationswe propose a pilot study based on a highly sensitive immune assay and our company s base technologyTrophoblast Retrieval and Isolation from the CervixTRICTRIC uses a Pap smearconsidere ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A therapeutic approach for potential prevention of aromatase inhibitor-induced bone loss
SBC: NANOMEDIC INC Topic: NIAAbstractIn this SBIR Phase I applicationour goal is to demonstrate proof of concept of our lead chelating agent as a potential therapeutic for the prevention of osteoporosis induced by aromatase inhibitorAItherapy in postmenopausal women with hormone receptor positive breast cancerAlthough AI therapy shows great improvements in cancer free and overall survivalits treated patients face a risk of os ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis
SBC: Zetroz Systems LLC Topic: NIAProject SummaryOsteoarthritisOAis the most common type of arthritisaffecting overmillion adults in the United States inand represents overof medical office visits according to the Centers for Disease Control and Prevention and the National Institutes of HealthOverof individuals overhave symptomatic OA and reduced mobility due to the diseaseOA pain is often mitigated with conservative treatment app ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Visible light activated implant devices to prevent biofilm formation
SBC: Sonata LLC Topic: NCEZIDPrevention of biofilms on invasive medical devices has the potential to significantly reduce hospital acquired infections and improve patient outcomesProsthetic joint infectionsPJIsacquired from orthopedic implantsoften the result of microorganism contamination on the implant surface during surgeryaffect patient recoveries and can lead to significant mortalitiesOne approach for reducing the incide ...
SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance
SBC: ISOPLEXIS CORPORATION Topic: 102Although signal transduction inhibitors occasionally offer clinical benefit for cancer patientssignal flux emanating from oncogenes is often distributed through multiple pathwayspotentially underlying the resistance which causes failure of most such inhibitorsMeasuring signal flux through multiple pathwaysin response to signal transduction inhibitorsmay help uncover network interactions that contr ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Use of Stem Cells to Enhance and Extend Continuous Glucose Monitoring in Vivo
SBC: Cell And Molecular Tissue Engineering LLC Topic: 200Implantable glucose sensor based monitoring of blood glucose levels in diabetic patients has been available for overyearsHoweverdespite improvements to sensor functionalityrecalibration of the sensor device is often a necessity in order to compensate for unreliable sensor performanceThe development of highly accurate and long lived implantable sensors is critical to the development of theartificia ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice
SBC: FIBROSIX INC. Topic: 102ABSTRACT Front-line therapy for patients diagnosed with Hodgkin’s lymphoma or germ cell cancers includes the drug bleomycin, a highly effective agent with a debilitating side effect. About 10-12% of bleomycin-treated patients develop pneumonitis with progression to pulmonary fibrosis during therapy as a direct result of bleomycin. An estimated 10-20% of these cases are fatal. The current standar ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of an a MC1R selective companion diagnostic imaging probe
SBC: MODULATION THERAPEUTICS, INC. Topic: 102The melanocortinreceptorMC Ris over expressed on uveal and cutaneous melanoma cellsbut notin healthy normal tissuesWe have developed a proprietary ligandMTIthat binds to MC R inmelanoma cells with high affinity and specificityThrough our SBIR Phase I contractwedemonstrated that MC R targetedAc DOTA MTIlacks of overt toxicity at single doses thatproduce significant efficacy against uveal and cutane ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
1-D Titania Nanostructure Based Wearable Alcohol Sensor with Tunable Sensitivity and Artificial Intelligence
SBC: NanoSynth Materials and Sensors Inc. Topic: 450PROJECT SUMMARY The overarching goal of this proposal is to develop an artificially intelligent alcohol sensor that is wearablenoninvasivesmartand aestheticThe aimin Phase Iis to design and develop the alcohol sensor based on metali eCobaltfunctionalized Titanium nanotubesTiNTto detectmonitorand display blood alcohol levels in real time using microcontrollers based wrist band like devicesAt the co ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel Small Molecule as a Radioprotector for Total Body Irradiation
SBC: Twenty First Century Therapeutics, Inc. Topic: NHLBIABSTRACT There are increased needs for effective radiation countermeasures that can protect bone marrowpromote the recovery of hematopoietic stem cellsHSCsor even increase survival rate from radiation induced damage in affected individualsIn generalradiation countermeasures may be divided into two areasradioprotection and radiomitigationThe focus of this project is on broad spectrum radioprotectio ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health